Daniel Dearborn's most recent trade in TuHURA Biosciences Inc. was a trade of 489,848 Options (Right to Buy) done . Disclosure was reported to the exchange on Nov. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 489,848 | 489,848 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 232,570 | 232,570 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 68,438 | 68,438 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 66,658 | 66,658 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 33,991 | 33,991 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 15,744 | 15,744 | - | - | Options (Right to Buy) |